Skip to main content

Table 2 Characteristics of HIV-exposed and infected children at initial evaluation in two rural clinics in Zambia by year of enrollment

From: Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study

 

First Year

N (%)

Second Year

N (%)

Third Year

N (%)

p-trenda

All children

N = 66

n = 159

n = 352

 

Age (yrs): Median (IQR)

3.1 (1.0, 8.1)

1.7 (0.6, 5.2)

0.4 (0.0, 1.9)

<0.0001

   <1

17 (25.8)

57 (35.9)

224 (63.6)

<0.0001

   1-1.9

9 (13.6)

31 (19.5)

46 (13.1)

 

   2-4.9

17 (25.8)

26 (16.4)

38 (10.8)

 

   5-9.9

14 (21.2)

29 (18.2)

31 (8.8)

 

   ≥ 10

9 (13.6)

16 (10.1)

13 (3.7)

 

Male sex

34 (51.5)

68 (42.8)

182 (51.7)

0.38

Distance travelled (km):

   

0.008

   Median (IQR)

22 (9, 40)

30 (13, 48)

35 (20, 50)

 

   Missing

11 (16.7)

41 (25.8)

80 (22.7)

 

HIV-infected children

N = 48

N = 99

n = 124

 

Age (yrs): Median (IQR)

4.9 (2.6, 9.3)

3.9 (1.9, 7.5)

2.8 (1.7, 6.5)

0.003

Male sex

24 (50.0)

41 (41.4)

66 (53.2)

0.39

Self-reported history of tuberculosis

13 (27.1)

11 (11.1)

15 (12.1)

0.04

WAZ: Median (IQR)

-3.0 (-3.8, -2.3)

-2.3 (-4.1, -1.5)

-3.0 (-3.9, -1.5)

 

   Underweight

27 (81.8)

43 (57.3)

69 (70.4)

0.71

   Missing

15 (31.3)

24 (24.2)

26 (21.0)

 

WHO stage

    

   1

4 (10.8)

9 (11.5)

16 (18.8)

0.04

   2

10 (27.0)

32 (41.0)

34 (40.0)

 

   3 or 4

23 (62.2)

37 (47.4)

35 (41.2)

 

   Missing

11 (22.9)

21 (21.2)

39 (31.5)

 

CD4%: Median (IQR)

19.0 (9.0, 25.0)

13.0 (9.5, 19.4)

20.2 (13.7, 27.6)

0.01

   Missing

41 (85.4)

50 (50.5)

45 (36.3)

 

   Severe immunodeficiencyb

3 (25.0)

36 (60.0)

36 (41.9)

0.59

CD4 count (cells/mm3):

    

   Median (IQR)

453 (257, 663)

513 (264, 786)

693 (338, 998)

0.01

   Missing

36 (75%)

39 (39.4)

38 (30.6)

 

Eligible for ARTc

22 (55.0)

58 (61.7)

61 (54.5)

0.69

   Missing

8 (16.7)

5 (5.1)

12 (9.7)

 
  1. IQR: interquartile range; WAZ: Weight-for-age z-score (only for children younger than 10 years); WHO: World Health Organization; ART: antiretroviral therapy.
  2. a p-trend calculated from Mantel-Haenszel χ2 for categorical variables and Cuzick's non-parametric test for trend for continuous variables.
  3. b severe immunodeficiency defined by age according to the 2006 WHO guidelines.
  4. c determined retrospectively based on the WHO guidelines in effect at the time of the initial evaluation